Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Garam Lee, Jeffrey Cummings, Boris Decourt, James B. Leverenz & Marwan N. Sabbagh. (2019) Clinical drug development for dementia with Lewy bodies: past and present. Expert Opinion on Investigational Drugs 28:11, pages 951-965.
Read now
Read now
Articles from other publishers (17)
Hubert H. Fernandez, Daniel Weintraub, Eric Macklin, Irene Litvan, Michael A. Schwarzschild, Jamie Eberling, Aleksandar Videnovic & Christopher J. Kenney. (2023) Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trial. Parkinsonism & Related Disorders 114, pages 105511.
Crossref
Crossref
Buer Song, Lifei Nie, Khurshed Bozorov, Rustamkhon Kuryazov, Haji Akber Aisa & Jiangyu Zhao. (2022) Parallel synthesis of condensed pyrimidine-thiones and their antitumor activities. Research on Chemical Intermediates 49:4, pages 1327-1348.
Crossref
Crossref
Ishani Landry, Nancy Hall, Jagadeesh Aluri, Gleb Filippov, Beatrice Setnik, Satish Dayal, Larisa Reyderman & Margaret Moline. (2022) Effect of alcohol coadministration on the pharmacodynamics, pharmacokinetics, and safety of lemborexant: A randomized, placebo-controlled crossover study. Journal of Psychopharmacology 36:6, pages 745-755.
Crossref
Crossref
Mrudhula Komanduri, Karen Savage, Ana Lea, Grace McPhee, Karen Nolidin, Saurenne Deleuil, Con Stough & Shakuntla Gondalia. (2021) The Relationship between Gut Microbiome and Cognition in Older Australians. Nutrients 14:1, pages 64.
Crossref
Crossref
Clémence Lacroix, Thomas Soeiro, Marguerite Le Marois, Romain Guilhaumou, Catherine Cassé-Perrot, Elisabeth Jouve, Claas Röhl, Raoul Belzeaux, Joëlle Micallef & Olivier Blin. (2021) Innovative approaches in CNS clinical drug development: Quantitative systems pharmacology. Therapies 76:2, pages 111-119.
Crossref
Crossref
Patricia Murphy, Dinesh Kumar, Gary Zammit, Russell Rosenberg & Margaret Moline. (2020) Safety of lemborexant versus placebo and zolpidem: effects on auditory awakening threshold, postural stability, and cognitive performance in healthy older participants in the middle of the night and upon morning awakening. Journal of Clinical Sleep Medicine 16:5, pages 765-773.
Crossref
Crossref
Fanaras Konstantinos & Reinhard Heun. (2019) The effects of Guarana (Paullinia cupana) supplementation on the cognitive performance of young healthy adults – a Systematic Review. Global Psychiatry 2:2, pages 171-182.
Crossref
Crossref
Keith A Wesnes, Cynthia McNamara & Peter Annas. (2016) Norms for healthy adults aged 18–87 years for the Cognitive Drug Research System: An automated set of tests of attention, information processing and memory for use in clinical trials. Journal of Psychopharmacology 30:3, pages 263-272.
Crossref
Crossref
Jonathan P. Roiser, Pradeep J. Nathan, Adrian P. Mander, Gabriel Adusei, Kenton H. Zavitz & Andrew D. Blackwell. (2016) Assessment of cognitive safety in clinical drug development. Drug Discovery Today 21:3, pages 445-453.
Crossref
Crossref
Kimford J. Meador, Haichen Yang, Jesus Eric Piña‐Garza, Antonio Laurenza, Dinesh Kumar & Keith A. Wesnes. (2016) Cognitive effects of adjunctive perampanel for partial‐onset seizures: A randomized trial. Epilepsia 57:2, pages 243-251.
Crossref
Crossref
Ian Zajac, Paul Cavuoto, Vanessa Danthiir, Gary A. Wittert, Debra Krause, Lindy Lawson, Manny Noakes, Julie Syrette, Julia Weaver & Louise Bennett. (2016) Study protocol: A randomised, double blinded, placebo-controlled clinical trial testing the effects of a vitamin D-enriched mushroom supplement on cognitive performance and mood in healthy elderly adults. Healthy Aging Research 5:5, pages 1-14.
Crossref
Crossref
Nathalie Pross, Alain Patat, Philippe Vivet, Michelle Bidaut & Nicolas Fauchoux. (2015) Pharmacodynamic interactions of a solid formulation of sodium oxybate and ethanol in healthy volunteers. British Journal of Clinical Pharmacology 80:3, pages 480-492.
Crossref
Crossref
Juri-Alexander Witt, Willem Alpherts & Christoph Helmstaedter. (2013) Computerized neuropsychological testing in epilepsy: Overview of available tools. Seizure 22:6, pages 416-423.
Crossref
Crossref
Adrian Wagg, Mark Dale, Reiner Tretter, Bridget Stow & Gerhard Compion. (2013) Randomised, Multicentre, Placebo-controlled, Double-blind Crossover Study Investigating the Effect of Solifenacin and Oxybutynin in Elderly People with Mild Cognitive Impairment: The SENIOR Study. European Urology 64:1, pages 74-81.
Crossref
Crossref
Vilem Novak, Radka Jeziorská & Marek Penhaker. 2013. Advanced Methods for Computational Collective Intelligence. Advanced Methods for Computational Collective Intelligence
207
216
.
Geoffrey C DunbarRamana V KuchibhatlaG Lee. (2010) A randomized double-blind study comparing 25 and 50 mg TC-1734 (AZD3480) with placebo, in older subjects with age-associated memory impairment. Journal of Psychopharmacology 25:8, pages 1020-1029.
Crossref
Crossref
Keith Wesnes. (2002) Assessing cognitive function in clinical trials: latest developments and future directions. Drug Discovery Today 7:1, pages 29-35.
Crossref
Crossref